The data thus far is impressive. Hopefully the next trial will follow suit and build on the momentum from the higher dose as it reaches PR quite swiftly >30% relief in tumor burden. Optimistic they have something special here. Time will tell and think also the US trial will really be a massive value creator with their different SOC. Other targets as well!
Ann: Presentation and Webinar, page-4
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.0¢ | $56.11K | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 231471 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 405423 | 4 |
View Market Depth
| Last trade - 13.27pm 21/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |